Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

Next Previous
Trial Profile

Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use

    • Most Recent Events

    • 28 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Sep 2019.
    • 28 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Mar 2019.
    • 14 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top